October Pharma profit skyrockets
Updated 11/15/2020 10:12:00 AM
ArabFinance: October Pharma reported a 228% Year on Year jump in its net profit for the first nine months of 2020, according to the company’s November 12th financial statements filed to the Egyptian Exchange.
Net profit after tax stood at EGP 60,669,184 in January-September 2020, compared to EGP 18,508,176 achieved in the prior-year period.
The company distributed cash dividends of EGP 1.50 per share on July 29th to the shareholders recorded on July 26th.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.
The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.
